AbbVie
ABBV
$244.64
Share price
3.22%
Change (1 day)
7.11%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : S$4.42 Billion
According to AbbVie's latest financial reports the company has S$4.42 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $S$4.57 B | -66.7% |
| 2023-12-31 | $S$13.73 B | -40.75% |
| 2022-12-31 | $S$23.17 B | 11.05% |
| 2021-12-31 | $S$20.86 B | 20.44% |
| 2020-12-31 | $S$17.32 B | -257.27% |
| 2019-12-31 | $-S$11.02 Billion | -4.52% |
| 2018-12-31 | $-S$11.54 Billion | -269.25% |
| 2017-12-31 | $S$6.81 B | 1.6% |
| 2016-12-31 | $S$6.70 B | 20.24% |
| 2015-12-31 | $S$5.58 B | 142.44% |
| 2014-12-31 | $S$2.30 B | -59.56% |
| 2013-12-31 | $S$5.69 B | 38.39% |
| 2012-12-31 | $S$4.11 B | -73.39% |
| 2011-12-31 | $S$15.45 B | -23.61% |
| 2010-12-31 | $S$20.22 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | S$116.29 B | 2,530.71% | 🇺🇸 USA |
 | S$21.53 B | 387.16% | 🇺🇸 USA |
 | S$18.75 B | 324.24% | 🇺🇸 USA |
 | S$7.72 B | 74.70% | 🇺🇸 USA |
 | S$25.29 B | 472.12% | 🇺🇸 USA |
 | S$21.96 B | 396.91% | 🇺🇸 USA |
 | S$21.57 B | 388.16% | 🇬🇧 UK |
 | S$53.70 B | 1,114.95% | 🇬🇧 UK |
 | S$3.40 B | -23.02% | 🇺🇸 USA |